The subsequent activation of the WNT/β-catenin signaling pathway following inhibition of GSK3β, was shown to attenuate infarct size, since the fibrotic area was approximately halved compared to controls at 7 days post-MI; at 14 days, the effect was still present but less prominent [53]. This evidence concerns the gene GSK3B and myocardial infarction.